Matches in SemOpenAlex for { <https://semopenalex.org/work/W2172238963> ?p ?o ?g. }
- W2172238963 endingPage "6" @default.
- W2172238963 startingPage "4111" @default.
- W2172238963 abstract "There are no reliable biomarkers for diagnosis, prediction of outcome or treatment effect monitoring for upper tract urothelial carcinoma (UTUC), which is a uniquely prevalent cancer in Taiwan. In the present study, 128 primary UTUC specimens of various grades and primary tumor status were examined for the expression of cyclooxygenase-2 (COX-2) in tumor and stroma tissues aiming to clarify the association of COX-2 expression with clinical outcomes in Taiwanese patients with UTUC.Immunohistochemistry was implemented to investigate COX-2 expression levels in 128 paired tumor and stroma specimens. The association of COX-2 expression with tumor progression and prognosis was analyzed.Our data demonstrated that positive COX-2 expression was more frequent in stromal cells (57.0%), than in tumor sites (53.1%), and the up-regulation of COX-2 was strongly associated with higher cancer-specific death and cancer recurrence rates. In COX-2-negative cases, no similar correlation was found.COX-2 expression was up-regulated in both stromal and tumor cells of more than half of the studied UTUC patients and the positive expression of COX-2 in stromal cells may be a potential predictive and prognostic biomarker for UTUC, especially for cancer-specific death and recurrence." @default.
- W2172238963 created "2016-06-24" @default.
- W2172238963 creator A5003914825 @default.
- W2172238963 creator A5021865992 @default.
- W2172238963 creator A5024318057 @default.
- W2172238963 creator A5038056354 @default.
- W2172238963 creator A5053001913 @default.
- W2172238963 creator A5056502618 @default.
- W2172238963 creator A5056676246 @default.
- W2172238963 creator A5057140486 @default.
- W2172238963 creator A5059442215 @default.
- W2172238963 creator A5075582846 @default.
- W2172238963 creator A5081019516 @default.
- W2172238963 date "2012-09-01" @default.
- W2172238963 modified "2023-09-23" @default.
- W2172238963 title "Cyclooxygenase-2 (COX-2) up-regulation is a prognostic marker for poor clinical outcome of upper tract urothelial cancer." @default.
- W2172238963 cites W1694383648 @default.
- W2172238963 cites W1715061133 @default.
- W2172238963 cites W1934055256 @default.
- W2172238963 cites W1970957601 @default.
- W2172238963 cites W1976247538 @default.
- W2172238963 cites W1981498432 @default.
- W2172238963 cites W1982947700 @default.
- W2172238963 cites W1987282771 @default.
- W2172238963 cites W1998399372 @default.
- W2172238963 cites W2001946685 @default.
- W2172238963 cites W2027078891 @default.
- W2172238963 cites W2030971688 @default.
- W2172238963 cites W2042691743 @default.
- W2172238963 cites W2045016464 @default.
- W2172238963 cites W2045462226 @default.
- W2172238963 cites W2058188039 @default.
- W2172238963 cites W2062504866 @default.
- W2172238963 cites W2063349142 @default.
- W2172238963 cites W2068401239 @default.
- W2172238963 cites W2080221673 @default.
- W2172238963 cites W2081761148 @default.
- W2172238963 cites W2083381988 @default.
- W2172238963 cites W2086030658 @default.
- W2172238963 cites W2094206460 @default.
- W2172238963 cites W2098100518 @default.
- W2172238963 cites W2101892819 @default.
- W2172238963 cites W2105593793 @default.
- W2172238963 cites W2124301980 @default.
- W2172238963 cites W2128075947 @default.
- W2172238963 cites W2128880078 @default.
- W2172238963 cites W2135100954 @default.
- W2172238963 cites W2141518861 @default.
- W2172238963 cites W2145482502 @default.
- W2172238963 cites W2152064969 @default.
- W2172238963 cites W2189579071 @default.
- W2172238963 cites W2275614507 @default.
- W2172238963 cites W2327667256 @default.
- W2172238963 cites W2801432109 @default.
- W2172238963 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22993369" @default.
- W2172238963 hasPublicationYear "2012" @default.
- W2172238963 type Work @default.
- W2172238963 sameAs 2172238963 @default.
- W2172238963 citedByCount "11" @default.
- W2172238963 countsByYear W21722389632013 @default.
- W2172238963 countsByYear W21722389632014 @default.
- W2172238963 countsByYear W21722389632015 @default.
- W2172238963 countsByYear W21722389632017 @default.
- W2172238963 countsByYear W21722389632018 @default.
- W2172238963 countsByYear W21722389632019 @default.
- W2172238963 countsByYear W21722389632022 @default.
- W2172238963 crossrefType "journal-article" @default.
- W2172238963 hasAuthorship W2172238963A5003914825 @default.
- W2172238963 hasAuthorship W2172238963A5021865992 @default.
- W2172238963 hasAuthorship W2172238963A5024318057 @default.
- W2172238963 hasAuthorship W2172238963A5038056354 @default.
- W2172238963 hasAuthorship W2172238963A5053001913 @default.
- W2172238963 hasAuthorship W2172238963A5056502618 @default.
- W2172238963 hasAuthorship W2172238963A5056676246 @default.
- W2172238963 hasAuthorship W2172238963A5057140486 @default.
- W2172238963 hasAuthorship W2172238963A5059442215 @default.
- W2172238963 hasAuthorship W2172238963A5075582846 @default.
- W2172238963 hasAuthorship W2172238963A5081019516 @default.
- W2172238963 hasConcept C121608353 @default.
- W2172238963 hasConcept C126322002 @default.
- W2172238963 hasConcept C142724271 @default.
- W2172238963 hasConcept C143998085 @default.
- W2172238963 hasConcept C16930146 @default.
- W2172238963 hasConcept C181199279 @default.
- W2172238963 hasConcept C204232928 @default.
- W2172238963 hasConcept C2779256057 @default.
- W2172238963 hasConcept C2779689624 @default.
- W2172238963 hasConcept C2781197716 @default.
- W2172238963 hasConcept C502942594 @default.
- W2172238963 hasConcept C50382708 @default.
- W2172238963 hasConcept C52124034 @default.
- W2172238963 hasConcept C55493867 @default.
- W2172238963 hasConcept C63363279 @default.
- W2172238963 hasConcept C71924100 @default.
- W2172238963 hasConcept C86803240 @default.
- W2172238963 hasConceptScore W2172238963C121608353 @default.
- W2172238963 hasConceptScore W2172238963C126322002 @default.
- W2172238963 hasConceptScore W2172238963C142724271 @default.